General Mills, Inc. (GIS) Stock Price Today
Key Stats
- $19.80BMARKET_CAP
- -VOLUME
- Consumer StaplesSECTOR
- $51.84FIFTY_TWO_WEEK_HIGH
- $32.17FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $33.29BENTERPRISE_VALUE
- 6.58%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track General Mills, Inc. (GIS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, General Mills, Inc. has traded between a low of $32.17 and a high of $51.84, highlighting its annual price range. Buy and sell General Mills, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Most Recent News
Wedbush celebrates 18 years with Cboe, highlighting market innovation and expanding digital asset trading.
Wedbush rang the closing bell at Cboe Global Markets to mark 18 years as a Cboe member, celebrating a partnership focused on innovation and market integrity. Since joining in 2008, Wedbush has supported the evolution of financial markets through new ...

Lawsuit challenges government-led censorship of Covid vaccine injury discussions on social media.
The New Civil Liberties Alliance (NCLA) filed an appeal to revive a lawsuit against the Biden Administration and private companies for censoring social media posts by individuals injured by Covid vaccines. Plaintiffs, including vaccine-injured indivi...

Investigation launched into Alignment Healthcare over alleged financial manipulation claims.
Hagens Berman has started investigating Alignment Healthcare after a whistleblower lawsuit accused the company of misclassifying expenses to inflate financial results for 2024 and 2025. The allegations claim this manipulation boosted key metrics, aff...
